During a Case-Based Roundtable® event, Ticiana Leal, MD, discusses phase 3 trials of combinations in the non–small cell lung ...

When Roberson was informed of his stay, he “praised God and thanked his supporters.” ...

SAN ANTONIO, October 18, 2024--bioAffinity Technologies announces pricing of $2.66 million registered direct offering and ...

A ChatGPT-like model can diagnose cancer, assist in selecting treatment options, and predict survival outcomes across various ...

Efforts to bring higher quality care to Johnson County residents have led to local health systems teaming up with national ...

The mRNA Revolution When the COVID-19 pandemic struck, the world's medical community initially prepared for a disaster of the scale of the Spanish Flu, which struck during WW1 and killed 50 million ...

Robert Roberson has received a stay of execution from the Texas Supreme Court. A new fight for Robeson’s life now begins.

The FDA has already made more than a dozen cancer drug approval decisions this year and more expected in the next several ...

The global organoids market is on the verge of extraordinary expansion, with industry forecasts predicting a rise to USD 1,306.4 million by 2024 and an impressive compound annual growth rate (CAGR) of ...